NBIX (STOCKS)
Neurocrine Biosciences Inc
$150.058600
-6.431400 (-4.11%)
Prev close: $156.490000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kyle W. Gano
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $15,337.82M
- Employees
- 1,800
- P/E (TTM)
- 22.93
- P/B (TTM)
- 4.30
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
14
Strong Buy
17
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$1.39 | $1.37 | +0.0208 | +1.52% |
|
Mar 2026 (Q1)
|
$1.91 | $1.20 | +0.7122 | +59.46% |
|
Dec 2025 (Q4)
|
$1.91 | $1.20 | +0.7122 | +59.46% |
|
Sep 2025 (Q3)
|
$2.04 | $1.62 | +0.4223 | +26.11% |
Financial Statements
| Revenues | $3.37B |
| Benefits Costs and Expenses | $2.43B |
| Costs And Expenses | $2.58B |
| Nonoperating Income/Loss | $145.40M |
| Operating Expenses | $2.53B |
| Selling, General, and Administrative Expenses | $1.35B |
| Other Operating Expenses | $1.18B |
| Operating Income/Loss | $794.80M |
| Income/Loss From Continuing Operations After Tax | $705.50M |
| Income/Loss From Continuing Operations Before Tax | $940.20M |
| Income Tax Expense/Benefit | $234.70M |
| Net Income/Loss | $705.50M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $705.50M |
| Net Income/Loss Available To Common Stockholders, Basic | $705.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $7.05 |
| Diluted Earnings Per Share | $6.82 |
| Basic Average Shares | 301,100,000 |
| Diluted Average Shares | 310,600,000 |
| Assets | $5.36B |
| Current Assets | $1.64B |
| Inventory | $104.20M |
| Prepaid Expenses | $217.10M |
| Other Current Assets | $1.32B |
| Noncurrent Assets | $3.72B |
| Fixed Assets | $90.50M |
| Intangible Assets | $2.23B |
| Other Non-current Assets | $1.41B |
| Liabilities | $1.67B |
| Current Liabilities | $874.50M |
| Wages | $123.20M |
| Other Current Liabilities | $751.30M |
| Noncurrent Liabilities | $791.00M |
| Equity | $3.69B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.69B |
| Liabilities And Equity | $5.36B |
| Net Cash Flow From Operating Activities | $898.10M |
| Net Cash Flow From Operating Activities, Continuing | $898.10M |
| Net Cash Flow From Investing Activities | -$891.20M |
| Net Cash Flow From Investing Activities, Continuing | -$891.20M |
| Net Cash Flow From Financing Activities | $60.20M |
| Net Cash Flow From Financing Activities, Continuing | $60.20M |
| Exchange Gains/Losses | -$200.00K |
| Net Cash Flow | $66.90M |
| Net Cash Flow, Continuing | $67.10M |
| Comprehensive Income/Loss | $698.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $698.10M |
| Other Comprehensive Income/Loss | -$7.40M |